Related Experiment Video

Updated: Jan 9, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.4K

Anticoagulant Therapy in Patients with Cirrhosis

Nicolas M Intagliata1, Patrick G Northup1

  • 1Division of Gastroenterology and Hepatology, University of Virginia Health System, University of Virginia, Charlottesville, Virginia.

Seminars in Thrombosis and Hemostasis
|June 7, 2015
PubMed

Insights

Cirrhosis patients face risks of bleeding and thrombosis. This review explores anticoagulation

Area of Science:

  • Hepatology and Thrombosis Research
  • Clinical Coagulation Studies

Background:

  • Cirrhosis is linked to complex coagulopathy, increasing risks for both bleeding and thrombosis.
  • Hypercoagulability in cirrhosis may worsen liver disease progression and fibrosis.
  • Venous and arterial thrombosis are significant concerns in patients with cirrhosis.

Purpose of the Study:

  • To review the current understanding of anticoagulation in cirrhosis.
  • To examine the efficacy and safety of anticoagulants for thrombosis in cirrhosis patients.
  • To explore the potential of anticoagulants in managing chronic liver disease progression.

Main Methods:

  • Literature review of recent studies on cirrhosis coagulopathy and thrombosis.
  • Analysis of clinical data regarding anticoagulation use in cirrhosis.
  • Examination of research on hypercoagulability and liver disease.

Main Results:

  • Cirrhosis patients are susceptible to both bleeding and thrombosis.
  • Hypercoagulability can accelerate hepatic decompensation and fibrosis.
  • Anticoagulation strategies for thrombosis in cirrhosis are emerging but require further research.

Conclusions:

  • Anticoagulation is a developing consideration for thrombosis in cirrhosis.
  • Risks and benefits of anticoagulation in cirrhosis remain unclear.
  • Further research is needed to guide anticoagulation therapy in this population.

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
185
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343